MedWatch

Former Vifor Pharma CEO had no knowledge of alleged Pharmacosmos smear campaign

In the years 2014–2016, Søren Tulstrup served as the chief executive of Vifor Pharma, which is now at the center of an antitrust investigation led by the EU Commission.

Søren Tulstrup previously served as CEO of Vifor Pharma, and is currently the CEO of Hansa Biopharma | Photo: Hansa Biopharma

”I did not know of any campaign back when I was leading Vifor. Monofer was obviously a product we were competing against, but there wasn’t any campaign at that point,” responds Søren Tulstrup when asked about EU Commission’s recently initiated antitrust investigation into the firm he used to spearhead.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs